AVAH vs. SGRY, CON, PRVA, WGS, VCYT, ARDT, ADUS, PGNY, PACS, and LFST
Should you be buying Aveanna Healthcare stock or one of its competitors? The main competitors of Aveanna Healthcare include Surgery Partners (SGRY), Concentra Group Holdings Parent (CON), Privia Health Group (PRVA), GeneDx (WGS), Veracyte (VCYT), Ardent Health (ARDT), Addus HomeCare (ADUS), Progyny (PGNY), PACS Group (PACS), and LifeStance Health Group (LFST). These companies are all part of the "healthcare" industry.
Aveanna Healthcare vs. Its Competitors
Surgery Partners (NASDAQ:SGRY) and Aveanna Healthcare (NASDAQ:AVAH) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, institutional ownership, earnings, valuation, profitability, risk and dividends.
In the previous week, Surgery Partners had 2 more articles in the media than Aveanna Healthcare. MarketBeat recorded 7 mentions for Surgery Partners and 5 mentions for Aveanna Healthcare. Surgery Partners' average media sentiment score of 0.48 beat Aveanna Healthcare's score of -0.20 indicating that Surgery Partners is being referred to more favorably in the media.
Surgery Partners has a beta of 1.9, suggesting that its stock price is 90% more volatile than the S&P 500. Comparatively, Aveanna Healthcare has a beta of 1.98, suggesting that its stock price is 98% more volatile than the S&P 500.
Aveanna Healthcare has lower revenue, but higher earnings than Surgery Partners. Surgery Partners is trading at a lower price-to-earnings ratio than Aveanna Healthcare, indicating that it is currently the more affordable of the two stocks.
Aveanna Healthcare has a net margin of 0.26% compared to Surgery Partners' net margin of -6.10%. Surgery Partners' return on equity of 2.41% beat Aveanna Healthcare's return on equity.
Surgery Partners presently has a consensus price target of $33.56, suggesting a potential upside of 50.34%. Aveanna Healthcare has a consensus price target of $5.10, suggesting a potential upside of 28.79%. Given Surgery Partners' stronger consensus rating and higher probable upside, analysts clearly believe Surgery Partners is more favorable than Aveanna Healthcare.
88.0% of Aveanna Healthcare shares are held by institutional investors. 2.3% of Surgery Partners shares are held by company insiders. Comparatively, 7.0% of Aveanna Healthcare shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.
Summary
Surgery Partners and Aveanna Healthcare tied by winning 8 of the 16 factors compared between the two stocks.
Get Aveanna Healthcare News Delivered to You Automatically
Sign up to receive the latest news and ratings for AVAH and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding AVAH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Aveanna Healthcare Competitors List
Related Companies and Tools
This page (NASDAQ:AVAH) was last updated on 7/21/2025 by MarketBeat.com Staff
